Home › Companies › SOLID BIOSCIENCES INC. › 2023-2024
At SOLID BIOSCIENCES INC.'s shareholder meeting held June 11, 2024, in the 2023-2024 proxy season, 55 asset managers reported how they voted in their SEC Form N-PX filings, covering 366 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. — SOLID BIOSCIENCES INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: SOLID BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and SOLID BIOSCIENCES INC.’s Form 8-K, filed June 11, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 11, 2024: 8 items on SOLID BIOSCIENCES INC.’s Form 8-K, filed June 11, 2024: 4 elected · 4 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore SOLID BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are SOLID BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Martin Freed | 23,745,352 | -- | -- | 8,358,068 | 2,550,388 | 74% | Elected | — |
| Elect Director: Ilan Ganot | 24,943,836 | -- | -- | 7,159,584 | 2,550,388 | 78% | Elected | — |
| Elect Director: Georgia Keresty | 25,008,876 | -- | -- | 7,094,544 | 2,550,388 | 78% | Elected | — |
| Elect Director: Ian Smith | 23,316,911 | -- | -- | 8,786,509 | 2,550,388 | 73% | Elected | — |
| 2. Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | 34,639,576 | 6,164 | 8,068 | -- | -- | 99.9% | Approved | — |
| 3. Company's stockholders approved an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 60,000,000 to 120,000,000 (the "Share Increase Ame | 34,363,600 | 214,815 | 75,393 | -- | -- | 99.3% | Approved | — |
| 4. An amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 2,000,000 shares | 22,598,749 | 9,501,620 | 3,051 | -- | 2,550,388 | 70% | Approved | — |
| 5. Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers. | 31,549,286 | 545,947 | 8,187 | -- | 2,550,388 | 98% | Approved | — |
This meeting is also recorded here as June 7, 2024; both records come from the same filing, so the date should be checked against it.
Source: SOLID BIOSCIENCES INC., Form 8-K, filed with the SEC on June 11, 2024 — read the filing on EDGAR.
Each item below shows how the 55 asset managers that disclosed a SOLID BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SOLID BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Georgia Keresty
SOLID BIOSCIENCES INC.’s own tally for this item (“Elect Director: Georgia Keresty”): 25,008,876 for, 7,094,544 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Martin Freed, Ilan Ganot, Georgia Keresty and Ian Smith as Class III directors to serve until the 2027 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 1,934,717 for, 104,743 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,236,124 | 0 | 0 | 0 | For |
| Invesco | 479,500 | 0 | 0 | 0 | For |
| Fidelity | 181,260 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 44,886 | Withhold |
| Dimensional | 0 | 0 | 0 | 33,328 | Withhold |
| American Century | 0 | 0 | 0 | 24,942 | Withhold |
| BlackRock | 23,563 | 0 | 0 | 0 | For |
| Charles Schwab | 10,276 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,323 | 0 | 0 | 0 | For |
| Equitable | 1,671 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 1,443 | Withhold |
| Nationwide | 0 | 0 | 0 | 121 | Withhold |
| Guggenheim | 0 | 0 | 0 | 23 | Withhold |
Combines 2 wordings of this item as funds reported it.
73% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Ian Smith
SOLID BIOSCIENCES INC.’s own tally for this item (“Elect Director: Ian Smith”): 23,316,911 for, 8,786,509 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Martin Freed, Ilan Ganot, Georgia Keresty and Ian Smith as Class III directors to serve until the 2027 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”
Support: 73% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 1,934,717 for, 104,743 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,236,124 | 0 | 0 | 0 | For |
| Invesco | 479,500 | 0 | 0 | 0 | For |
| Fidelity | 181,260 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 44,886 | Withhold |
| Dimensional | 0 | 0 | 0 | 33,328 | Withhold |
| American Century | 0 | 0 | 0 | 24,942 | Withhold |
| BlackRock | 23,563 | 0 | 0 | 0 | For |
| Charles Schwab | 10,276 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,323 | 0 | 0 | 0 | For |
| Equitable | 1,671 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 1,443 | Withhold |
| Nationwide | 0 | 0 | 0 | 121 | Withhold |
| Guggenheim | 0 | 0 | 0 | 23 | Withhold |
Combines 2 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Ilan Ganot
SOLID BIOSCIENCES INC.’s own tally for this item (“Elect Director: Ilan Ganot”): 24,943,836 for, 7,159,584 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Martin Freed, Ilan Ganot, Georgia Keresty and Ian Smith as Class III directors to serve until the 2027 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 1,934,717 for, 104,743 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,236,124 | 0 | 0 | 0 | For |
| Invesco | 479,500 | 0 | 0 | 0 | For |
| Fidelity | 181,260 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 44,886 | Withhold |
| Dimensional | 0 | 0 | 0 | 33,328 | Withhold |
| American Century | 0 | 0 | 0 | 24,942 | Withhold |
| BlackRock | 23,563 | 0 | 0 | 0 | For |
| Charles Schwab | 10,276 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,323 | 0 | 0 | 0 | For |
| Equitable | 1,671 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 1,443 | Withhold |
| Nationwide | 0 | 0 | 0 | 121 | Withhold |
| Guggenheim | 0 | 0 | 0 | 23 | Withhold |
Combines 2 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Martin Freed
SOLID BIOSCIENCES INC.’s own tally for this item (“Elect Director: Martin Freed”): 23,745,352 for, 8,358,068 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Martin Freed, Ilan Ganot, Georgia Keresty and Ian Smith as Class III directors to serve until the 2027 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 698,593 for, 1,340,867 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 1,236,124 | Withhold |
| Invesco | 479,500 | 0 | 0 | 0 | For |
| Fidelity | 181,260 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 44,886 | Withhold |
| Dimensional | 0 | 0 | 0 | 33,328 | Withhold |
| American Century | 0 | 0 | 0 | 24,942 | Withhold |
| BlackRock | 23,563 | 0 | 0 | 0 | For |
| Charles Schwab | 10,276 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,323 | 0 | 0 | 0 | For |
| Equitable | 1,671 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 1,443 | Withhold |
| Nationwide | 0 | 0 | 0 | 121 | Withhold |
| Guggenheim | 0 | 0 | 0 | 23 | Withhold |
Combines 3 wordings of this item as funds reported it.
99.3% Approved · of votes cast
Description as filed by funds: The approval of an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 60,000,000 to 120,000,000.
SOLID BIOSCIENCES INC.’s own tally for this item (“3. The Company's stockholders approved an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 60,000,000 to 120,000,000 (the”): 34,363,600 for, 214,815 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 60,000,000 to 120,000,000 (the "Share Increase Ame”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 2,039,460 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,236,124 | 0 | 0 | 0 | For |
| Invesco | 479,500 | 0 | 0 | 0 | For |
| Fidelity | 181,260 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 44,886 | 0 | 0 | 0 | For |
| Dimensional | 33,328 | 0 | 0 | 0 | For |
| American Century | 24,942 | 0 | 0 | 0 | For |
| BlackRock | 23,563 | 0 | 0 | 0 | For |
| Charles Schwab | 10,276 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,323 | 0 | 0 | 0 | For |
| Equitable | 1,671 | 0 | 0 | 0 | For |
| John Hancock | 1,443 | 0 | 0 | 0 | For |
| Nationwide | 121 | 0 | 0 | 0 | For |
| Guggenheim | 23 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
70% Approved · of votes cast
Description as filed by funds: The approval of an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 2,000,000 shares.
SOLID BIOSCIENCES INC.’s own tally for this item (“4. An amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 2,000,000 shares”): 22,598,749 for, 9,501,620 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4: The Company's stockholders approved an amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 2,000,000 shares.”
Support: 70% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 14 asset managers below reported 2,046,720 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 1,236,124 | 0 | 0 | Against |
| Invesco | 0 | 479,500 | 0 | 0 | Against |
| Fidelity | 0 | 181,260 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 44,886 | 0 | 0 | Against |
| Dimensional | 0 | 33,328 | 0 | 0 | Against |
| American Century | 0 | 24,942 | 0 | 0 | Against |
| BlackRock | 0 | 23,563 | 0 | 0 | Against |
| Charles Schwab | 0 | 10,276 | 0 | 0 | Against |
| ALGERT GLOBAL LLC | 0 | 7,260 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 2,323 | 0 | 0 | Against |
| Equitable | 0 | 1,671 | 0 | 0 | Against |
| John Hancock | 0 | 1,443 | 0 | 0 | Against |
| Nationwide | 0 | 121 | 0 | 0 | Against |
| Guggenheim | 0 | 23 | 0 | 0 | Against |
Combines 4 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.
SOLID BIOSCIENCES INC.’s own tally for this item (“5. The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”): 31,549,286 for, 545,947 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,236,124 | 0 | 0 | 0 | For |
| Invesco | 479,500 | 0 | 0 | 0 | For |
| Fidelity | 181,260 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 44,886 | 0 | 0 | Against |
| Dimensional | 33,328 | 0 | 0 | 0 | For |
| American Century | 0 | 24,942 | 0 | 0 | Against |
| BlackRock | 23,563 | 0 | 0 | 0 | For |
| Charles Schwab | 10,276 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,323 | 0 | 0 | 0 | For |
| Equitable | 1,671 | 0 | 0 | 0 | For |
| John Hancock | 1,443 | 0 | 0 | 0 | For |
| Nationwide | 121 | 0 | 0 | 0 | For |
| Guggenheim | 23 | 0 | 0 | 0 | For |
Fund voting reports, all 13 managers: 1,969,632 for, 69,828 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 6,601,815 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 4,330,446 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 4,034,582 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,404,159 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,260,398 | 0 | 0 | 0 | For |
| Janus Henderson | 1,604,725 | 0 | 0 | 0 | For |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,228,187 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 1,024,520 | 0 | 0 | 0 | For |
| Finepoint Capital LP | 961,251 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 735,011 | 0 | 0 | 0 | For |
| Invesco | 479,500 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 414,615 | 0 | 0 | Against |
| BlackRock | 258,825 | 3,043 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 204,673 | 0 | 0 | 0 | For |
| Goldman Sachs | 110,679 | 0 | 0 | 0 | For |
| Two Sigma | 109,159 | 0 | 0 | 0 | For |
| State Street | 72,988 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 45,872 | 0 | 0 | Against |
| Renaissance | 45,057 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 32,375 | 0 | 0 | 0 | For |
| American Century | 0 | 24,942 | 0 | 0 | Against |
| Northern Trust | 24,836 | 0 | 0 | 0 | For |
| Atom Investors LP | 13,310 | 0 | 0 | 0 | For |
| BOULDER HILL CAPITAL MANAGEMENT LP | 10,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,276 | 0 | 0 | 0 | For |
Institutional-manager reports, all 50 managers: 26,610,809 for, 488,472 against, 83 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
— Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: THE HOLDING OF AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE EXECUTIVE COMPENSATION ADVISORY VOTES.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| Guggenheim | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 13 managers: 2,006,132 1 year, 33,328 3 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0 | 0 | 0 | 0 | -- |
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Vestal Point Capital, LP | 0 | 0 | 0 | 0 | -- |
| Finepoint Capital LP | 0 | 0 | 0 | 0 | -- |
| Laurion Capital Management LP | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Alyeska Investment Group, L.P. | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Atom Investors LP | 0 | 0 | 0 | 0 | -- |
| BOULDER HILL CAPITAL MANAGEMENT LP | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 45 managers: 83 not voted, 17,013,723 1 year, 13,310 unknown, 7,262 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
SOLID BIOSCIENCES INC.’s own tally for this item (“2. The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 34,639,576 for, 6,164 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 2,039,460 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,236,124 | 0 | 0 | 0 | For |
| Invesco | 479,500 | 0 | 0 | 0 | For |
| Fidelity | 181,260 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 44,886 | 0 | 0 | 0 | For |
| Dimensional | 33,328 | 0 | 0 | 0 | For |
| American Century | 24,942 | 0 | 0 | 0 | For |
| BlackRock | 23,563 | 0 | 0 | 0 | For |
| Charles Schwab | 10,276 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,323 | 0 | 0 | 0 | For |
| Equitable | 1,671 | 0 | 0 | 0 | For |
| John Hancock | 1,443 | 0 | 0 | 0 | For |
| Nationwide | 121 | 0 | 0 | 0 | For |
| Guggenheim | 23 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 38,379,413 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.22% |
| 2 | Invesco | 1.25% |
| 3 | Fidelity | 0.47% |
| 4 | BRIDGEWAY FUNDS INC | 0.12% |
| 5 | Dimensional | 0.09% |
| 6 | American Century | 0.06% |
| 7 | BlackRock | 0.06% |
| 8 | Charles Schwab | 0.03% |
| 9 | MASTER INVESTMENT PORTFOLIO | <0.01% |
| 10 | Equitable | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 17.20% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 11.28% |
| 3 | Bain Capital Life Sciences Investors, LLC | 10.51% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.26% |
| 5 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5.89% |
| 6 | Janus Henderson | 4.18% |
| 7 | SILVERARC CAPITAL MANAGEMENT, LLC | 3.20% |
| 8 | Vestal Point Capital, LP | 2.67% |
| 9 | Finepoint Capital LP | 2.50% |
| 10 | Laurion Capital Management LP | 1.92% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Perceptive Advisors LLC | — | 13D |
| RA Capital Management, L.P. | — | 13D |
| Raymond Debbane | — | 13G |
| Perceptive Life Sciences Master Fund Ltd. and affiliated entities | — | DEF14A |
| Adage Capital Management, L.P. | — | 13G |
| BCLS II Investco, LP | — | 13D |
| COMMODORE CAPITAL LP | — | 13G |
| BlackRock | — | 13F |
| Entities affiliated with RA Capital Management, L.P. | — | DEF14A |
| Rajeev Shah | — | DEF14A |
Percentages above are of 38,379,413 shares outstanding, as reported by SOLID BIOSCIENCES INC. on its Form 10-Q dated May 10, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SOLID BIOSCIENCES INC.’s 10-Q dated May 10, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
SOLID BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “SOLID BIOSCIENCES (SLDB) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/solid-biosciences-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.